
About Primogenix
Primogenix was a Healthcare company based in Columbia (United States) founded in 2003 by Robin Wesselschmidt. It specializes in deriving pluripotent mouse ES cell lines for research. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biotechnology, Cell Line Development and Stem Cell Research. Its competitors include BioLife Solutions, RoosterBio and ArunA Bio; 2 of its 3 listed competitors have raised funding.
Company details
Primogenix, founded in 2003 in Columbia, United States, focuses on providing healthcare solutions, advancing biotech innovations, cell line development, and stem cell research. Specializes in deriving pluripotent mouse ES cell lines for research. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Columbia, United States
- Founders Robin Wesselschmidt
- SectorsHealthcare
- Website primogenix.com
People of Primogenix
1 people are tracked at Primogenix (1 in leadership).
| Name | Role | Group |
|---|---|---|
Robin Wesselschmidt | Founder | Leadership |
Complete people profiles for Primogenix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Primogenix
Primogenix has 3 listed competitors in our database, 2 of them funded. They include BioLife Solutions, RoosterBio and ArunA Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | ||
| roosterbio.com | 2012 | Frederick, United States | $38.41M | 69 | Developer of human mesenchymal stem cells and extracellular vesicles | |
| arunabio.com | 2017 | Athens, United States | $38.51M | Neural exosome platform is developed for neurodegenerative disease therapeutics. |
Detailed competitors of Primogenix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Primogenix
Websites that share an audience with Primogenix (primogenix.com).
Websites whose visitors overlap most with Primogenix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| intercytex.com | 100% | View details | |||
| pluristem.com | 78% | View details |
Top companies in Cell Therapy
3 companies that operate in the same segment as Primogenix (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Primogenix
Primogenix was founded in 2003.
Primogenix is headquartered in Columbia, United States.
Primogenix, founded in 2003 in Columbia, United States, focuses on providing healthcare solutions, advancing biotech innovations, cell line development, and stem cell research. Specializes in deriving pluripotent mouse ES cell lines for research. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Primogenix's top competitors include RoosterBio, BioLife Solutions and ArunA Bio.